Zymeworks received financing from CTI Life Sciences Fund and private investors with the support of technology development grants from the Canadian National Research Council Industrial Research Assistance Program (NRC-IRAP).
Exisiting shareholders may obtain additional specific information about the Company by entering their username and password. If you are not a current investor and would like to learn more about Zymeworks, you may request access by contacting Dr. Ali Tehrani directly.